Related Experiment Video
Updated: Sep 19, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Cooperation between oncogenic NRF2 and wild-type HRAS promotes progression of breast cancer
Su-Jung Kim1, Soma Saeidi1, Nam-Chul Cho2
1Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, South Korea.
Abstract:
HRAS is often overactivated in breast cancer, whereas mutations are rare in this malignancy. This study was aimed to determine how overexpressed wild-type HRAS (HRASWT) plays an oncogenic role in human breast cancer progression. The activated form of non-mutagemic HRASWT is highly overexpressed in aggressive triple-negative breast cancer (TNBC) compared with less invasive luminal breast tumor as well as normal mammary tissues. A qPCR assay showed that TNBC cells selectively overexpress HRASWT. Notably, HRAS directly interacted with and stabilized NRF2 whereas KRAS barely bound to NRF2. Further, HRASWT exerted its oncogenic capability by inducing interaction between NRF2 and STAT3. Such interaction was observed in TNBC tissues, but not other subtypes of breast cancer. Combined silencing of NRF2 and STAT3 suppressed TNBC growth to a greater extent than that achieved with single knockdown of individual genes. RNA sequencing analysis revealed expression profiles for genes related to cell migration which may account for synergistic oncogenic activity of NRF2 and STAT3. Our results suggest that NRF2 is a potential effector of HRAS that regulates downstream signaling in a KEAP1-independent manner. Non-mutated HRAS overexpression, in cooperation with NRF2, promotes the progression of breast carcinoma and might represent a novel therapeutic target against TNBC.
More Related Videos
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Related Concept Videos
The Ras Gene
Ras is a...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...